Changing treatments for overactive bladder.
Overactive bladder is a common urological diagnosis which is often untreated as patients fail to seek help for this embarrassing problem. Elizabeth Waine and Mark Stott summarise the symptoms and investigations for overactive bladder and provide an overview of the treatments available.
Waine
Elizabeth
E
Royal Devon and Exeter NHS Trust.
Stott
Mark
M
D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D018727:Muscarinic Antagonists / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D010276:Parasympatholytics / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D053201:Urinary Bladder, Overactive / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D053202:Urinary Incontinence, Urge / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy
D018727:Muscarinic Antagonists; D009465:Neuromuscular Agents; D010276:Parasympatholytics; D019274:Botulinum Toxins, Type A